Wed, January 22, 2025
[ Wed, Jan 22nd ]: WOPRAI
As of Jan 22nd, 2025, there has been substantial .. f Nature's Miracle Holding Inc. in recent trading
[ Wed, Jan 22nd ]: WOPRAI
As of Jan 22nd, 2025, there has been substantial selling of PlantX Life Inc. in recent trading
[ Wed, Jan 22nd ]: WOPRAI
As of Jan 22nd, 2025, there has been substantial selling of Mobilicom Limited in recent trading
[ Wed, Jan 22nd ]: WOPRAI
As of Jan 22nd, 2025, there has been substantial .. lling of Armada Mercantile Ltd. in recent trading
[ Wed, Jan 22nd ]: WOPRAI
As of Jan 22nd, 2025, there has been substantial .. ing of Entheon Biomedical Corp. in recent trading
[ Wed, Jan 22nd ]: WOPRAI
As of Jan 22nd, 2025, there has been substantial .. ling of Gen 2 Technologies Inc. in recent trading
[ Wed, Jan 22nd ]: WOPRAI
As of Jan 22nd, 2025, there has been substantial selling of in recent trading
[ Wed, Jan 22nd ]: WOPRAI
105 Earnings Releases for Jan 22nd, 2025
[ Wed, Jan 22nd ]: MSN
Amazon's SWOT analysis: cloud giant's stock poised for growth amid AI boom
Tue, January 21, 2025
[ Tue, Jan 21st ]: MarketWatch
Stock Market Today: Dow and S&P rise as Nasdaq wo .. s slip. Apple stock down, Netflix earnings ahead.
[ Tue, Jan 21st ]: MSN
How To Invest In Stocks And Place Your First Trade
[ Tue, Jan 21st ]: MSN
CoreCivic, GEO Group stocks rise as Trump revokes Biden orders
[ Tue, Jan 21st ]: MSN
Tesla, Apple Slide Among Tuesday's Market Cap Stock Movers
[ Tue, Jan 21st ]: Kiplinger
Apple Stock Slapped With Another Sell Rating: What to Know
[ Tue, Jan 21st ]: MSN
Best AI Stocks: C3.ai vs. SoundHound AI vs. BigBear.ai
[ Tue, Jan 21st ]: bnnbloomberg
Lode Gold looks to unlock value on gold projects in Canada, U.S.
[ Tue, Jan 21st ]: Forbes
Trump's Return: What It Means For Alternative Investments
[ Tue, Jan 21st ]: MarketWatch
Tech-sector's dominance 'now the biggest economic story in Washington'
[ Tue, Jan 21st ]: MSN
How to Potentially Double Your Money Through Investing
[ Tue, Jan 21st ]: AOL
The Best Vanguard Index ETF to Invest $200 in Right Now
[ Tue, Jan 21st ]: Kiplinger
Getting Divorced? Beware of Hidden Tax Traps as You Divide Assets
[ Tue, Jan 21st ]: MSN
Best all-weather SCHD ETF stocks to buy and hold in 2025
[ Tue, Jan 21st ]: Indiatimes
Jio Financial, BlackRock expand operations with new broking venture
[ Tue, Jan 21st ]: MSN
Why J.B. Hunt Transport Services, Inc. (JBHT) Is One of the Best Shipping Stocks to Invest in Now?
[ Tue, Jan 21st ]: WOPRAI
119 Earnings Releases for Jan 21st, 2025
Orbitz
Mon, January 20, 2025
[ Mon, Jan 20th ]: Forbes
4 Big Cap Oil Stocks: Breaking Out And Hitting New Highs
[ Mon, Jan 20th ]: Kiplinger
5 Tips for Investing in the Trump Presidency
[ Mon, Jan 20th ]: Yahoo
Space infrastructure company Redwire to buy Edge Autonomy for $925 million
[ Mon, Jan 20th ]: Reuters
Focus: Trump Media's true believers bet on stock surge as presidency begins
[ Mon, Jan 20th ]: FXStreet
Are banks the new defensive play?
[ Mon, Jan 20th ]: Forbes
Trump's 'Drill Baby Drill' - Why SLB Could Lead Energy Sector In 2025
[ Mon, Jan 20th ]: MSN
AMD: Loop Capital's Buy Rating Reinforces Investor Confidence
[ Mon, Jan 20th ]: BBC
Trump urges US Supreme Court to delay TikTok ban
[ Mon, Jan 20th ]: MSN
2 things that could sink the Lloyds share price in 2025
[ Mon, Jan 20th ]: MSN
2 Reasons I'm Bullish on Uber Stock
[ Mon, Jan 20th ]: Yahoo
Nvidia Stock Has Started 2025 Slowly. Get Used to It.
[ Mon, Jan 20th ]: MSN
3 Subtle Investing Mistakes I Won't Repeat in 2025 And Beyond
[ Mon, Jan 20th ]: MSN
3 Pieces of Noise to Ignore With Bitcoin, Solana, and Ethereum
[ Mon, Jan 20th ]: AOL
3 Vanguard ETFs to Buy With $2,000 and Hold Forever
[ Mon, Jan 20th ]: MSN
Kore Potash reveals major shareholders' stakes
[ Mon, Jan 20th ]: MSN
Is it time to boot underperforming Fundsmith Equity out of my Stocks and Shares ISA?
[ Mon, Jan 20th ]: WOPRAI
As of Jan 20th, 2025, there has been substantial selling of Alvotech in recent trading
[ Mon, Jan 20th ]: WOPRAI
As of Jan 20th, 2025, there has been substantial selling of Plug Power Inc. in recent trading
[ Mon, Jan 20th ]: WOPRAI
As of Jan 20th, 2025, there has been substantial selling of AEye, Inc. in recent trading
[ Mon, Jan 20th ]: WOPRAI
As of Jan 20th, 2025, there has been substantial .. ling of Metallis Resources Inc. in recent trading
[ Mon, Jan 20th ]: WOPRAI
As of Jan 20th, 2025, there has been substantial .. ing of BIGG Digital Assets Inc. in recent trading
[ Mon, Jan 20th ]: WOPRAI
As of Jan 20th, 2025, there has been substantial .. Cumberland Pharmaceuticals Inc. in recent trading
[ Mon, Jan 20th ]: WOPRAI
As of Jan 20th, 2025, there has been substantial selling of SES AI Corporation in recent trading

DIY Woodworking

Announcing The World''s Largest Collection of 16,000 Woodworking Plans

Is Tarsus Pharmaceuticals (TARS) Among Billionaire Joseph Edelman's Long-Term Stock Picks?

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. aire-joseph-edelman-s-long-term-stock-picks.html
  Print publication without navigation Published in Stocks and Investing on by MSN
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
We recently published a list of Billionaire Joseph Edelman's Top 10 Long-Term Stock Picks. In this article, we are going to take a look at where Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) stands against other Billionaire Joseph Edelman's long-term stock picks.
The article from MSN Money discusses whether Tarsus Pharmaceuticals (TARS) is among billionaire Joseph Edelman's long-term stock picks. Tarsus Pharmaceuticals, known for its focus on developing novel therapeutics for ophthalmic conditions, has caught the attention of investors due to its promising pipeline, particularly with its lead candidate TP-03 for the treatment of Demodex blepharitis. The piece highlights Edelman's investment strategy, which often involves backing companies with significant growth potential in niche markets. It notes that while Edelman has invested in Tarsus, the long-term commitment to the stock remains uncertain as his investment decisions can be influenced by various factors including clinical trial outcomes, market conditions, and competitive landscape changes. The article also provides insights into Tarsus's recent developments, financial health, and market performance, suggesting that while there is potential for growth, investors should consider the inherent risks associated with biotech investments.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/top-stocks/is-tarsus-pharmaceuticals-tars-among-billionaire-joseph-edelman-s-long-term-stock-picks/ar-AA1xxy2i ]